Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Collegium Pharmaceutical (COLL) Gross Profit (2016 - 2026)

Collegium Pharmaceutical has reported Gross Profit over the past 10 years, most recently at $128.4 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 30.61% year-over-year to $128.4 million; the TTM value through Dec 2025 reached $463.3 million, up 22.77%, while the annual FY2025 figure was $463.3 million, 22.77% up from the prior year.
  • Gross Profit for Q4 2025 was $128.4 million at Collegium Pharmaceutical, down from $129.2 million in the prior quarter.
  • Over five years, Gross Profit peaked at $129.2 million in Q3 2025 and troughed at -$1.3 million in Q4 2021.
  • A 5-year average of $76.3 million and a median of $78.9 million in 2023 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: tumbled 103.01% in 2021 and later soared 3835.11% in 2022.
  • Year by year, Gross Profit stood at -$1.3 million in 2021, then soared by 3835.11% to $49.8 million in 2022, then soared by 90.06% to $94.6 million in 2023, then increased by 3.87% to $98.3 million in 2024, then skyrocketed by 30.61% to $128.4 million in 2025.
  • Business Quant data shows Gross Profit for COLL at $128.4 million in Q4 2025, $129.2 million in Q3 2025, and $108.4 million in Q2 2025.